Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.
Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.
Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Brainjo uses virtual reality (VR) and brain-computer interfaces for treating ADHD, providing a modern approach to mental health care.
Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.
Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.
Bonum Therapeutics creates a technology platform to treat a wide range of diseases.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.
Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.
Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.
Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.
Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked